172 related articles for article (PubMed ID: 23603614)
1. Cell-free carrier system for localized delivery of peripheral blood cell-derived engineered factor signaling: towards development of a one-step device for autologous angiogenic therapy.
Hadjipanayi E; Bauer AT; Moog P; Salgin B; Kuekrek H; Fersch B; Hopfner U; Meissner T; Schlüter A; Ninkovic M; Machens HG; Schilling AF
J Control Release; 2013 Jul; 169(1-2):91-102. PubMed ID: 23603614
[TBL] [Abstract][Full Text] [Related]
2. First implantable device for hypoxia-mediated angiogenic induction.
Hadjipanayi E; Cheema U; Mudera V; Deng D; Liu W; Brown RA
J Control Release; 2011 Aug; 153(3):217-24. PubMed ID: 21458514
[TBL] [Abstract][Full Text] [Related]
3. Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors.
Losi P; Briganti E; Magera A; Spiller D; Ristori C; Battolla B; Balderi M; Kull S; Balbarini A; Di Stefano R; Soldani G
Biomaterials; 2010 Jul; 31(20):5336-44. PubMed ID: 20381861
[TBL] [Abstract][Full Text] [Related]
4. Injectable system for spatio-temporally controlled delivery of hypoxia-induced angiogenic signalling.
Hadjipanayi E; Cheema U; Hopfner U; Bauer A; Machens HG; Schilling AF
J Control Release; 2012 Aug; 161(3):852-60. PubMed ID: 22634070
[TBL] [Abstract][Full Text] [Related]
5. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Bai Y; Bai L; Zhou J; Chen H; Zhang L
Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
[TBL] [Abstract][Full Text] [Related]
6. Regeneration through autologous hypoxia preconditioned plasma.
Hadjipanayi E; Schilling AF
Organogenesis; 2014; 10(2):164-9. PubMed ID: 24831225
[TBL] [Abstract][Full Text] [Related]
7. Engineered mesenchymal cell-based patches as controlled VEGF delivery systems to induce extrinsic angiogenesis.
Boccardo S; Gaudiello E; Melly L; Cerino G; Ricci D; Martin I; Eckstein F; Banfi A; Marsano A
Acta Biomater; 2016 Sep; 42():127-135. PubMed ID: 27469308
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
9. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.
d'Angelo I; Oliviero O; Ungaro F; Quaglia F; Netti PA
Acta Biomater; 2013 Jul; 9(7):7389-98. PubMed ID: 23523534
[TBL] [Abstract][Full Text] [Related]
10. Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels.
He S; Xia T; Wang H; Wei L; Luo X; Li X
Acta Biomater; 2012 Jul; 8(7):2659-69. PubMed ID: 22484697
[TBL] [Abstract][Full Text] [Related]
11. A novel in vitro assay for human angiogenesis.
Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
[TBL] [Abstract][Full Text] [Related]
12. A novel targeted angiogenesis technique using VEGF conjugated magnetic nanoparticles and in-vitro endothelial barrier crossing.
Arokiaraj MC
BMC Cardiovasc Disord; 2017 Jul; 17(1):209. PubMed ID: 28754088
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast-derived matrix (FDM) as a novel vascular endothelial growth factor delivery platform.
Du P; Hwang MP; Noh YK; Subbiah R; Kim IG; Bae SE; Park K
J Control Release; 2014 Nov; 194():122-9. PubMed ID: 25194780
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor.
Xu H; Czerwinski P; Hortmann M; Sohn HY; Förstermann U; Li H
Cardiovasc Res; 2008 May; 78(2):349-55. PubMed ID: 18056764
[TBL] [Abstract][Full Text] [Related]
15. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds.
Kampmann A; Lindhorst D; Schumann P; Zimmerer R; Kokemüller H; Rücker M; Gellrich NC; Tavassol F
Microvasc Res; 2013 Nov; 90():71-9. PubMed ID: 23899416
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiogenic factors and 3D-microenvironments on vascularization within sandwich cultures.
Nishiguchi A; Matsusaki M; Asano Y; Shimoda H; Akashi M
Biomaterials; 2014 Jun; 35(17):4739-48. PubMed ID: 24655783
[TBL] [Abstract][Full Text] [Related]
17. Spatially guided angiogenesis by three-dimensional collagen scaffolds micropatterned with vascular endothelial growth factor.
Oh HH; Lu H; Kawazoe N; Chen G
J Biomater Sci Polym Ed; 2012; 23(17):2185-95. PubMed ID: 22127352
[TBL] [Abstract][Full Text] [Related]
18. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors.
Briganti E; Spiller D; Mirtelli C; Kull S; Counoupas C; Losi P; Senesi S; Di Stefano R; Soldani G
J Control Release; 2010 Feb; 142(1):14-21. PubMed ID: 19811766
[TBL] [Abstract][Full Text] [Related]
19. The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen-glycosaminoglycan scaffold in vivo.
McFadden TM; Duffy GP; Allen AB; Stevens HY; Schwarzmaier SM; Plesnila N; Murphy JM; Barry FP; Guldberg RE; O'Brien FJ
Acta Biomater; 2013 Dec; 9(12):9303-16. PubMed ID: 23958783
[TBL] [Abstract][Full Text] [Related]
20. Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFβ1) in the regulation of ovarian angiogenesis.
Kuo SW; Ke FC; Chang GD; Lee MT; Hwang JJ
J Cell Physiol; 2011 Jun; 226(6):1608-19. PubMed ID: 20945379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
